Codeine use and harms in Australia: evaluating the effects of re-scheduling

R. CAIRNS ; A. L. SCHAFFER ; J. A. BROWN ; S. A. PEARSON ; N. A. BUCKLEY | 2020
Dans Addiction (Vol.115, n°3, March 2020) Article : Périodique

BACKGROUND AND AIMS: Globally, codeine is the most-used opioid. In December 2016, Australia announced that low-strength codeine (

Plus d'info

Ajouter à la sélection

Lien externe

Gabapentinoids: repeating mistakes of the past? [Editorial]

B. MURNION ; A. SCHAFFER ; R. CAIRNS ; J. BRETT | 2022
Dans Addiction (Vol.117, n°12, December 2022) Article : Périodique

Gabapentinoid abuse and harms are increasing proportional to increased prescribing. Despite early indicators of problems and similar patterns with other drugs, regulatory controls over promotion and availability were introduced only after signif[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre

R. CAIRNS ; J. A. BROWN ; N. GUNJA ; N. A. BUCKLEY | 2017
Dans International Journal of Drug Policy (Vol.43, May 2017) Article : Périodique

Background: The emergence of new psychoactive substances (NPS), including synthetic cannabinoid receptor agonists (SCRAs) poses novel challenges for drug regulation and public health. Misconceptions of safety and legality, coupled with the fact [...]

Plus d'info

Ajouter à la sélection